Clinical effects of TECAR therapy in the conservative management of Stage 2 lipedema in females: A randomized controlled trial
As an adjunct to standard care, TECAR therapy appears to reduce pain and limb volume and enhance overall quality of life in Stage 2 lipedema. Further long-term studies are needed to confirm these findings.
Authors
- Didem Sezgin Özcan (ORCID: https://orcid.org/0000-0003-0246-3001)
- Meltem Dalyan (ORCID: https://orcid.org/0000-0002-7341-2888)
- Öznur Uzun (ORCID: https://orcid.org/0000-0002-3888-1064)
- Hüma Bölük Şenlikçi (ORCID: https://orcid.org/0000-0001-6771-3265)
- Zeynep Atalay (ORCID: https://orcid.org/0009-0007-0668-0544)
- Rüçhan Ünal (ORCID: https://orcid.org/0009-0003-0791-6708)
Institutions
- Memorial Ankara Hospital (TR)
- Başkent University Hospital (TR)
Publication Details
- Journal
- Turkish Journal of Physical Medicine and Rehabilitation
- Published
- 2025-11-10
- DOI
- https://doi.org/10.5606/tftrd.2025.17157
- Citations
- 1
- Primary Topic
- Lymphatic System and Diseases
- Type
- article
- Field-Weighted Citation Impact
- 1.05